What is Cymbiotika?
CYMBIOTIKA operates as an online supplement store, focusing on natural and organic health products. The company offers a diverse portfolio of supplements designed to address various health needs, including immunity, skin health, fitness, and stress management. Cymbiotika enhances its customer value proposition through subscription services, complimentary shipping for orders exceeding $150, and strategic alliances with wellness applications, providing a holistic approach to personal and pet health support. The company targets health-conscious consumers seeking premium supplements for their well-being.
How much funding has Cymbiotika raised?
Cymbiotika has raised a total of $55.1M across 3 funding rounds:
Debt
$68K
Debt
$30M
Seed
$25M
Debt (2021): $68K with participation from PPP
Debt (2024): $30M led by RevTek Capital
Seed (2025): $25M, investors not publicly disclosed
Key Investors in Cymbiotika
RevTek Capital
RevTek Capital is noted for providing cost-effective and rapid funding solutions for early-stage, emerging growth companies with recurring revenue. They are recognized for their proficiency in analyzing financing needs and offering responsive solutions, often acting as a direct decision-maker in their flat organizational structure. RevTek Capital also offers operational insights and strategic connections to further business development.
PPP
Public-Private Partnership
What's next for Cymbiotika?
The recent major strategic investment in Cymbiotika signals a pivotal phase for the company, likely indicating a move towards scaling operations, expanding market reach, and potentially developing new product lines. Given the enterprise-level funding context, Cymbiotika is poised for significant growth, possibly exploring new distribution channels or enhancing its technological infrastructure to support a larger customer base. This capital infusion will be critical in solidifying its competitive advantage in the burgeoning health supplement market.
See full Cymbiotika company page
